BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1085 related articles for article (PubMed ID: 25400806)

  • 41. Fulminant Epstein-Barr virus-associated T-cell lymphoproliferative disorder in an immunocompetent middle-aged man presenting with chronic diarrhea and gastrointestinal bleeding.
    Abdul-Ghafar J; Kim JW; Park KH; Cho MY
    J Korean Med Sci; 2011 Aug; 26(8):1103-7. PubMed ID: 21860564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical and pathological analysis of three cases of childhood systemic EB virus positive T-cell lymphoproliferative disease].
    Wang W; Ti HJ; Nong L; Zhang S; Zhang Y; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):594-8. PubMed ID: 22898854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus-related lymph node lesion resembling autoimmune disease-like clinicopathological findings in elderly patients. Report of three cases.
    Kojima M; Yamane Y; Itoh H; Tanaka H; Sugihara S; Masawa N; Nakamura S
    APMIS; 2003 Dec; 111(12):1083-8. PubMed ID: 14678016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
    Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F
    Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease.
    Takeuchi M; Sato Y; Yasui H; Ozawa H; Ohno K; Takata K; Gion Y; Orita Y; Tachibana T; Itoh T; Asano N; Nakamura S; Swerdlow SH; Yoshino T
    Am J Surg Pathol; 2014 Jul; 38(7):946-55. PubMed ID: 24705309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS.
    Hayashi K; Jin Z; Onoda S; Joko H; Teramoto N; Ohara N; Oda W; Tanaka T; Liu YX; Koirala TR; Oka T; Kondo E; Yoshino T; Takahashi K; Akagi T
    Am J Pathol; 2003 May; 162(5):1721-36. PubMed ID: 12707056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits.
    Hayashi K; Ohara N; Teramoto N; Onoda S; Chen HL; Oka T; Kondo E; Yoshino T; Takahashi K; Yates J; Akagi T
    Am J Pathol; 2001 Apr; 158(4):1533-42. PubMed ID: 11290571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome.
    Ohshima K; Suzumiya J; Sugihara M; Nagafuchi S; Ohga S; Kikuchi M
    Pathol Int; 1998 Dec; 48(12):934-43. PubMed ID: 9952337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts.
    Ng SB; Ohshima K; Selvarajan V; Huang G; Choo SN; Miyoshi H; Wang S; Chua HC; Yeoh AE; Quah TC; Koh LP; Tan PL; Chng WJ
    Orphanet J Rare Dis; 2014 Dec; 9():165. PubMed ID: 25475054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Elevation of Epstein-Barr virus (EBV)-DNA in the peripheral blood of a patient with age-related EBV-associated B-cell lymphoproliferative disorder].
    Tanioka R; Mori S; Nakanishi T; Fujita S; Nakamichi N; Tajima K; Uemura Y; Amakawa R; Kishimoto Y; Fukuhara S
    Rinsho Ketsueki; 2007 Nov; 48(11):1492-7. PubMed ID: 18080508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
    Kawabe S; Ito Y; Gotoh K; Kojima S; Matsumoto K; Kinoshita T; Iwata S; Nishiyama Y; Kimura H
    Cancer Sci; 2012 Aug; 103(8):1481-8. PubMed ID: 22497716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis.
    Lin MT; Chang HM; Huang CJ; Chen WL; Lin CY; Lin CY; Chuang SS
    J Clin Pathol; 2007 Jan; 60(1):101-3. PubMed ID: 17213357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.
    Brown HA; Macon WR; Kurtin PJ; Gibson LE
    J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus (EBV)-related lymphoproliferative disorder with subsequent EBV-negative T-cell lymphoma.
    Tao Q; Srivastava G; Loke SL; Liang RH; Liu YT; Ho FC
    Int J Cancer; 1994 Jul; 58(1):33-9. PubMed ID: 8014013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
    Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
    Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
    Suzumiya J; Ohshima K; Kanda M; Kumagawa M; Nagano M; Hirata M; Nawa Y; Tamura K; Kikuchi M
    Leuk Lymphoma; 2000 May; 37(5-6):593-604. PubMed ID: 11042520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E; Cornelissen JJ
    Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Rapid Cytologic Double Staining of Epstein-Barr Virus-encoded Small RNA and Cell Surface Markers for Diagnosis of Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis.
    Takahashi N; Kudo K; Tanaka M; Kumagai N; Sato T; Kamio T; Sasaki S; Terui K; Kurose A; Yanagisawa R; Nakazawa Y; Ito E
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):e756-e758. PubMed ID: 31743316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.